Invention Grant
- Patent Title: Modulators of cortical dopaminergic- and NMDA-receptor-mediated glutamatergic neurotransmission
-
Application No.: US14603661Application Date: 2015-01-23
-
Publication No.: US09120728B2Publication Date: 2015-09-01
- Inventor: Clas Sonesson , Jonas Karlsson , Peder Svensson
- Applicant: INTEGRATIVE RESEARCH LABORATORIES SWEDEN AB
- Applicant Address: SE Göteborg
- Assignee: Integrative Research Laboratories Sweden AB
- Current Assignee: Integrative Research Laboratories Sweden AB
- Current Assignee Address: SE Göteborg
- Agency: Ballard Spahr LLP
- Priority: DK201170187 20110419; DK201170495 20110906
- Main IPC: C07D211/22
- IPC: C07D211/22 ; C07D295/088 ; C07D205/04 ; C07C317/22
Abstract:
The present invention relates to novel substituted phenoxyethylamine derivatives, useful as modulators of cortical and basal ganglia dopaminergic and N-methyl-D-aspartate (NMDA) receptor-mediated glutamatergic neurotransmission. In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.
Public/Granted literature
- US20150148426A1 NOVEL MODULATORS OF CORTICAL DOPAMINERGIC- AND NMDA-RECEPTOR-MEDIATED GLUTAMATERGIC NEUROTRANSMISSION Public/Granted day:2015-05-28
Information query
